These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 15956757

  • 1. Coevolution of the relaxin-like peptides and their receptors.
    Wilkinson TN, Speed TP, Tregear GW, Bathgate RA.
    Ann N Y Acad Sci; 2005 May; 1041():534-9. PubMed ID: 15956757
    [Abstract] [Full Text] [Related]

  • 2. Relaxin-3, INSL5, and their receptors.
    Liu C, Lovenberg TW.
    Results Probl Cell Differ; 2008 May; 46():213-37. PubMed ID: 18236022
    [Abstract] [Full Text] [Related]

  • 3. Evolution of the signaling system in relaxin-family peptides.
    Hsu SY, Semyonov J, Park JI, Chang CL.
    Ann N Y Acad Sci; 2005 May; 1041():520-9. PubMed ID: 15956755
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Membrane receptors: structure and function of the relaxin family peptide receptors.
    Kong RC, Shilling PJ, Lobb DK, Gooley PR, Bathgate RA.
    Mol Cell Endocrinol; 2010 May 14; 320(1-2):1-15. PubMed ID: 20138959
    [Abstract] [Full Text] [Related]

  • 7. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7.
    Liu C, Chen J, Kuei C, Sutton S, Nepomuceno D, Bonaventure P, Lovenberg TW.
    Mol Pharmacol; 2005 Jan 14; 67(1):231-40. PubMed ID: 15465925
    [Abstract] [Full Text] [Related]

  • 8. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
    Halls ML, Bond CP, Sudo S, Kumagai J, Ferraro T, Layfield S, Bathgate RA, Summers RJ.
    J Pharmacol Exp Ther; 2005 May 14; 313(2):677-87. PubMed ID: 15649866
    [Abstract] [Full Text] [Related]

  • 9. Recent progress in relaxin-3-related research.
    Liu C, Bonaventure P, Sutton SW, Chen J, Kuei C, Nepomuceno D, Lovenberg TW.
    Ann N Y Acad Sci; 2005 May 14; 1041():47-60. PubMed ID: 15956687
    [Abstract] [Full Text] [Related]

  • 10. Relaxin research in the postgenomic era.
    Kawamura K, Sudo S, Kumagai J, Pisarska M, Hsu SY, Bathgate R, Wade J, Hsueh AJ.
    Ann N Y Acad Sci; 2005 May 14; 1041():1-7. PubMed ID: 15956679
    [Abstract] [Full Text] [Related]

  • 11. Identification of binding sites with differing affinity and potency for relaxin analogues on LGR7 and LGR8 receptors.
    Halls ML, Bathgate RA, Sudo S, Kumagai J, Bond CP, Summers RJ.
    Ann N Y Acad Sci; 2005 May 14; 1041():17-21. PubMed ID: 15956682
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the rat INSL3 receptor.
    Scott DJ, Fu P, Shen PJ, Gundlach A, Layfield S, Riesewijk A, Tomiyama H, Hutson JM, Tregear GW, Bathgate RA.
    Ann N Y Acad Sci; 2005 May 14; 1041():13-6. PubMed ID: 15956681
    [Abstract] [Full Text] [Related]

  • 13. Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity.
    Muda M, He C, Martini PG, Ferraro T, Layfield S, Taylor D, Chevrier C, Schweickhardt R, Kelton C, Ryan PL, Bathgate RA.
    Mol Hum Reprod; 2005 Aug 14; 11(8):591-600. PubMed ID: 16051677
    [Abstract] [Full Text] [Related]

  • 14. G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135.
    Sutton SW, Bonaventure P, Kuei C, Nepomuceno D, Wu J, Zhu J, Lovenberg TW, Liu C.
    Neuroendocrinology; 2005 Aug 14; 82(3-4):139-50. PubMed ID: 16679775
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like factor 3: where are we now?
    Ivell R, Hartung S, Anand-Ivell R.
    Ann N Y Acad Sci; 2005 May 14; 1041():486-96. PubMed ID: 15956750
    [Abstract] [Full Text] [Related]

  • 16. Relaxin family peptide receptors--from orphans to therapeutic targets.
    van der Westhuizen ET, Halls ML, Samuel CS, Bathgate RA, Unemori EN, Sutton SW, Summers RJ.
    Drug Discov Today; 2008 Aug 14; 13(15-16):640-51. PubMed ID: 18675759
    [Abstract] [Full Text] [Related]

  • 17. Genetic targeting of relaxin and insl3 signaling in mice.
    Feng S, Bogatcheva NV, Kamat AA, Agoulnik AI.
    Ann N Y Acad Sci; 2005 May 14; 1041():82-90. PubMed ID: 15956690
    [Abstract] [Full Text] [Related]

  • 18. Studies on soluble ectodomain proteins of relaxin (LGR7) and insulin 3 (LGR8) receptors.
    Yan Y, Cai J, Fu P, Layfield S, Ferraro T, Kumagai J, Sudo S, Tang JG, Giannakis E, Tregear GW, Wade JD, Bathgate RA.
    Ann N Y Acad Sci; 2005 May 14; 1041():35-9. PubMed ID: 15956685
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.